Ponnarambil, S.
7  Ergebnisse:
Personensuche X
?
1

LOWER INCIDENCE OF HYPEREOSINOPHILIA WITH TEZEPELUMAB TREAT..:

Carr, W. ; Ponnarambil, S. ; Hunter, G....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S55 , 2023
 
?
2

TEZEPELUMAB REDUCES ALL KEY INFLAMMATORY BIOMARKER LEVELS I..:

Mathur, S. ; Jacobs, J. ; Ponnarambil, S....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S43 , 2023
 
?
3

TEZEPELUMAB EFFICACY IN PATIENTS WITH SEVERE ASTHMA BY BLOO..:

Wechsler, M. ; Carr, T. ; Ponnarambil, S....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S45-S46 , 2023
 
?
4

TIMING OF EXACERBATIONS WITH TEZEPELUMAB VERSUS PLACEBO IN ..:

Hill, J. ; Mathur, S. ; Molfino, N....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S44 , 2023
 
?
5

EFFICACY OF TEZEPELUMAB IN HISPANIC OR LATINO PATIENTS WITH..:

Hill, J. ; Carr, T. ; Ambrose, C....
Annals of Allergy, Asthma & Immunology.  129 (2022)  5 - p. S35-S36 , 2022
 
?
6

EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLL..:

Jain, N. ; Llanos-Ackert, J. ; Ambrose, C....
Annals of Allergy, Asthma & Immunology.  129 (2022)  5 - p. S36-S37 , 2022
 
1-7